A timely review of state-of-the-art chronopharmaceuticals synchronized with biological rhythms.
暂无分享,去创建一个
[1] A. Prończuk,et al. Nutritional correlates and dynamics of diabetes in the Nile rat (Arvicanthis niloticus): a novel model for diet-induced type 2 diabetes and the metabolic syndrome , 2010, Nutrition & Metabolism.
[2] Sobia Rana,et al. Circadian rhythm and its role in malignancy , 2010, Journal of circadian rhythms.
[3] P. Burge. Recent developments in occupational asthma. , 2010, Swiss medical weekly.
[4] M. Beckett,et al. Mechanisms by which circadian rhythm disruption may lead to cancer , 2010 .
[5] V. Lotlikar,et al. Pulsatile delivery systems: An approach for chronotherapeutic diseases , 2010 .
[6] A. Chacko,et al. Chronotherapeutics and Chronotherapeutic Drug Delivery Systems , 2009 .
[7] J. Sabarinathan,et al. Near-infrared optical response of thin film pH-sensitive hydrogel coated on a gold nanocrescent array. , 2009, Optics express.
[8] V. Pillay,et al. Drug delivery technologies for chronotherapeutic applications , 2009, Pharmaceutical development and technology.
[9] M. Fujii,et al. Novel chronotherapeutic rectal aminophylline delivery system for therapy of asthma. , 2009, International journal of pharmaceutics.
[10] J. Kenny,et al. Stimuli responsive hydrogels prepared by frontal polymerization. , 2009, Biomacromolecules.
[11] M. Geetha,et al. Optimization and Development of Swellable Controlled Porosity Osmotic Pump Tablet for Theophylline , 2009 .
[12] M. Bonsignore,et al. Metabolic aspects of obstructive sleep apnoea syndrome , 2009, European Respiratory Review.
[13] Aliasgar Shahiwala,et al. Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[14] P. Colombo,et al. Novel Platforms for Oral Drug Delivery , 2009, Pharmaceutical Research.
[15] H. Frijlink,et al. Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[16] L. Geddes. Circadian rhythms provide guide for cancer therapies , 2008 .
[17] Xing Tang,et al. In vitro and in vivo evaluation of ofloxacin sustained release pellets. , 2008, International journal of pharmaceutics.
[18] J. Nie,et al. A pH‐sensitive water‐soluble N‐carboxyethyl chitosan/poly(hydroxyethyl methacrylate) hydrogel as a potential drug sustained release matrix prepared by photopolymerization technique , 2008 .
[19] M. Ishida,et al. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules. , 2008, International journal of pharmaceutics.
[20] P. Mura,et al. Development of enteric-coated calcium pectinate microspheres intended for colonic drug delivery. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[21] Tetsuo Shimizu,et al. Expression profiles of 10 circadian clock genes in human peripheral blood mononuclear cells , 2008, Neuroscience Research.
[22] M. Shoaib,et al. Formulation development and optimization of Ibuprofen tablets by direct compression method. , 2008, Pakistan journal of pharmaceutical sciences.
[23] T. Velten,et al. Drug delivery from the oral cavity: focus on a novel mechatronic delivery device. , 2008, Drug discovery today.
[24] Linfeng Wu,et al. Surface crosslinking for delayed release of proxyphylline from PHEMA hydrogels. , 2008, International journal of pharmaceutics.
[25] J. Jacobs,et al. Glucocorticoid chronotherapy in rheumatoid arthritis , 2008, The Lancet.
[26] F. Turek,et al. Sleep and circadian rhythms: Key components in the regulation of energy metabolism , 2008, FEBS letters.
[27] R. Minutolo,et al. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[28] Francesco Portaluppi,et al. Circadian rhythms in cardiac arrhythmias and opportunities for their chronotherapy. , 2007, Advanced drug delivery reviews.
[29] B. Bruguerolle,et al. Rhythmic pattern in pain and their chronotherapy. , 2007, Advanced drug delivery reviews.
[30] Michael H Smolensky,et al. Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. , 2007, Advanced drug delivery reviews.
[31] Francis Lévi,et al. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics. , 2007, Advanced drug delivery reviews.
[32] Nicholas A Peppas,et al. Chronobiology, drug delivery, and chronotherapeutics. , 2007, Advanced drug delivery reviews.
[33] O. Froy. The relationship between nutrition and circadian rhythms in mammals , 2007, Frontiers in Neuroendocrinology.
[34] D. Puleo,et al. Bioerodible devices for intermittent release of simvastatin acid. , 2007, International journal of pharmaceutics.
[35] S. Ponrathnam,et al. Low density porous carrier based conceptual drug delivery system , 2007 .
[36] J. Stehle,et al. The mammalian pineal gland: known facts, unknown facets , 2007, Trends in Endocrinology & Metabolism.
[37] N. Ishida. Circadian clock, cancer and lipid metabolism , 2007, Neuroscience Research.
[38] G. Marshall,et al. Montelukast in the management of allergic rhinitis , 2007, Therapeutics and clinical risk management.
[39] A. R. Kulkarni,et al. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma. , 2007, International journal of pharmaceutics.
[40] Wei Wu,et al. Characterization of 5-Fluorouracil Release from Hydroxypropylmethylcellulose Compression-Coated Tablets , 2007, Pharmaceutical development and technology.
[41] James Lyons-Weiler,et al. Molecular overlap of fly circadian rhythms and human pancreatic cancer. , 2006, Cancer letters.
[42] K. Kadota,et al. Clock mutation affects circadian regulation of circulating blood cells , 2006, Journal of circadian rhythms.
[43] A. Dashevsky,et al. Development of pulsatile multiparticulate drug delivery system coated with aqueous dispersion Aquacoat ECD. , 2006, International journal of pharmaceutics.
[44] A. Pawar,et al. Low density multiparticulate system for pulsatile release of meloxicam. , 2006, International journal of pharmaceutics.
[45] D. Bikiaris,et al. Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer. , 2006, International journal of pharmaceutics.
[46] M. Vlachou,et al. Design and evaluation of a dry coated drug delivery system with an impermeable cup, swellable top layer and pulsatile release. , 2006, International journal of pharmaceutics.
[47] N. Peppas,et al. Assemblage of novel release modules for the development of adaptable drug delivery systems. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[48] C. Takimoto. Chronomodulated chemotherapy for colorectal cancer: failing the test of time? , 2006, European journal of cancer.
[49] J. Krueger,et al. Links between the innate immune system and sleep. , 2005, The Journal of allergy and clinical immunology.
[50] Ueli Schibler,et al. The daily rhythms of genes, cells and organs , 2005, EMBO reports.
[51] Johannes D Veldhuis,et al. Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans. , 2005, Diabetes.
[52] R. Hermida,et al. Chronotherapy Improves Blood Pressure Control and Reverts the Nondipper Pattern in Patients With Resistant Hypertension , 2008, Hypertension.
[53] H. Sekhon,et al. Vitamin C prevents the effects of prenatal nicotine on pulmonary function in newborn monkeys. , 2005, American journal of respiratory and critical care medicine.
[54] R. Hermida,et al. P-149: Administration time-dependent effects of amlodipine on ambulatory blood pressure in patients with essential hypertension , 2005 .
[55] R. Hermida,et al. OR-6: Administration time-dependent efficacy of valsartan-atorvastatin combination in hyperlipidemic patients with essential hypertension , 2005 .
[56] R. Hermida,et al. P-150: Differing effects of awakening versus bedtime valsartan administration on urinary albumin excretion in hypertensive patients , 2005 .
[57] C. Green. Time for chronotherapy? Clock genes dictate sensitivity to cyclophosphamide. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[58] V. Stella,et al. Applicability of (SBE)7m-β-CD in controlled-porosity osmotic pump tablets (OPTs) , 2004 .
[59] J. Born,et al. Preserved circadian rhythm of serum insulin concentration at low plasma glucose during fasting in lean and overweight humans. , 2004, Metabolism: clinical and experimental.
[60] W. Storms. Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis. , 2004, The Journal of allergy and clinical immunology.
[61] A. Rawat,et al. Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization. , 2004, International journal of pharmaceutics.
[62] X. Zhu,et al. Polymer microspheres for controlled drug release. , 2004, International journal of pharmaceutics.
[63] M. P. Danckwerts,et al. A novel compression-coated doughnut-shaped tablet design for zero-order sustained release. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[64] F. Lévi,et al. It is time for chronotherapy! , 2003, Pathologie-biologie.
[65] R. Singh,et al. Circadian variation of basal total vascular tone and chronotherapy in patients with vasospastic angina pectoris. , 2002, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[66] G. Skloot. Nocturnal asthma: mechanisms and management. , 2002, The Mount Sinai journal of medicine, New York.
[67] S. Garg,et al. Formulation aspects in the development of osmotically controlled oral drug delivery systems. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[68] M. Weber. The 24-hour blood pressure pattern: does it have implications for morbidity and mortality? , 2002, The American journal of cardiology.
[69] E. Shimizu,et al. Theophylline chronotherapy of nocturnal asthma using bathyphase of circadian rhythm in peak expiratory flow rate. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[70] B. Lemmer. Relevance for chronopharmacology in practical medicine. , 2000, Seminars in perinatology.
[71] K. Zhu,et al. Pulsatile protein release from a laminated device comprising polyanhydrides and pH-sensitive complexes. , 2000, International journal of pharmaceutics.
[72] J. Cui,et al. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings. , 1999, International journal of pharmaceutics.
[73] M. Smolensky,et al. Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease. , 1999, American heart journal.
[74] R. Lockey,et al. Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes. , 1999, Chest.
[75] S. Neau,et al. Sustained release theophylline tablets by direct compression: Part 1: formulation and in vitro testing , 1998 .
[76] R. Martin,et al. Further studies on the chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. , 1997, The Journal of allergy and clinical immunology.
[77] M. Tobyn,et al. Influence of processing variables on physical properties of timerx , 1996 .
[78] Richard W. Baker,et al. Osmotic drug delivery : a review of the patent literature , 1995 .
[79] L. Ackerson,et al. Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. , 1995, The Journal of allergy and clinical immunology.
[80] S. Soong,et al. The time of administration of 3'-azido-3'-deoxythymidine (AZT) determines its host toxicity with possible relevance to AZT chemotherapy , 1993, Antimicrobial Agents and Chemotherapy.
[81] W. R. Beam,et al. Timing of prednisone and alterations of airways inflammation in nocturnal asthma. , 1992, The American review of respiratory disease.
[82] G. Zentner,et al. Controlled porosity solubility- and resin-modulated osmotic drug delivery systems for release of diltiazem hydrochloride , 1991 .
[83] M. Turner-Warwick,et al. Epidemiology of nocturnal asthma. , 1988, The American journal of medicine.
[84] W. Arkinstall. Review of the North American experience with evening administration of Uniphyl tablets, a once-daily theophylline preparation, in the treatment of nocturnal asthma. , 1988, The American journal of medicine.
[85] S. Leslie. The Contin delivery system: dosing considerations. , 1986, The Journal of allergy and clinical immunology.
[86] M. Smolensky,et al. Clinical significance of day-night differences in serum theophylline concentration with special reference to Theo-Dur. , 1986, The Journal of allergy and clinical immunology.
[87] M. Knapp,et al. Lymphocytes are rhythmic: is this important? , 1984, British medical journal.
[88] A. Pradalier,et al. Pharmacokinetics of theophylline in night-workers. , 1982, British journal of clinical pharmacology.
[89] E. Raftery,et al. CIRCADIAN VARIATION OF BLOOD-PRESSURE , 1978, The Lancet.
[90] R. Haag,et al. Pharmaceutically used polymers: principles, structures, and applications of pharmaceutical delivery systems. , 2010, Handbook of experimental pharmacology.
[91] M. An,et al. Formulation and Evaluation of Timed Delayed Capsule Device for Chronotherapeutic Delivery of Terbutaline Sulphate , 2010 .
[92] D. Bikiaris,et al. Recent advances in oral pulsatile drug delivery. , 2009, Recent patents on drug delivery & formulation.
[93] K. Reddy,et al. REVIEW ON: PULSATILE DRUG DELIVERY SYSTEMS , 2009 .
[94] A. Gazzaniga,et al. Oral pulsatile delivery systems based on swellable hydrophilic polymers. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[95] R. Straub,et al. Circadian rhythms in arthritis: hormonal effects on the immune/inflammatory reaction. , 2008, Autoimmunity reviews.
[96] P. Sher,et al. Development of hollow/porous calcium pectinate beads for floating-pulsatile drug delivery. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[97] D. Generali,et al. The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load. , 2007, Bone.
[98] M. Turkoğlu,et al. In vitro evaluation of pectin-HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[99] M. Weber,et al. A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning. , 2001, American journal of hypertension.
[100] M. Smolensky,et al. Biological Rhythms and Medicine , 1983, Topics in Environmental Physiology and Medicine.